ProciseDx Instrument and CRP Test Receive FDA Clearance
ProciseDx Inc. announces it has received FDA clearance for its ProciseDx instrument and C reactive Protein (CRP) test.
Read More
Search Results for: liver disease
Llusern Debuts UTI Molecular Diagnostic Platform
UK diagnostics manufacturer, Llusern Scientific, will preview its Lodestar DX molecular diagnostic platform at the upcoming Medica 2022.
Read More
Alimentiv, Summit Clinical Research Collaborate to Support Non-Alcoholic Steatohepatitis Clinical Trials
Alimentiv and Summit Clinical Research are collaborating to drive Non-Alcoholic Steatohepatitis drug development programs forward.
Read More
The Binding Site To Be Acquired by Thermo Fisher
Nordic Capital and Five Arrows have entered into a definitive agreement to sell The Binding Site to Thermo Fisher Scientific.
Read More
New AI Tech Predicts Diagnostic Concordance For Melanoma, Proscia Says
Proscia released study results on new AI that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer.
Read More